LATEST NEWS
More
A novel method for delineation of oral mucosa for radiotherapy dose–response...
Mucositis of the oral mucosa is a common and important acute toxicity in head and neck radiotherapy warranting efforts to mitigate its severity and...
Reduced Bone Fractures In Breast Cancer : Amgen Presents Phase 3...
Amgen today announced results from a randomized, double-blind, placebo-controlled, multicenter Phase 3 study evaluating the treatment effect of adjuvant Prolia® (denosumab), 60 mg once...
SPECIALITTY AREAS
- All
- ASCO 2016
- Ash 2014
- brain tumor
- Breast cancer
- Cancer
- Chemotherapy
- CLL
- Conferences
- ECCO 2017
- Embedded Technology
- EONS 10
- ESMO
- Featured
- Imaging Technology
- Leukaemia
- Lung cancer
- Media
- Medical Devices
- Melanoma
- Metastatic
- Neutropenia
- Oncology
- Oncology Nursing
- Oropharyngeal cancer
- Ovarian cancer
- Pharmacy
- Prevention
- Prostate cancer
- Public Health
- Radio therapy
- Rare Tumors
- Rectal Cancer
- Research
- Sarcoma
- Specialities
- T cell
- Thyroid cancer
- vaccine
- Videos
- Viruses & Bacteria
- Wireless Technology
More
LATEST ARTICLES
- Advertisement -
